Clinical Trial Update: Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating eltrombopag with or without a hypomethylating agent after hypomethylating agent failure in patients with myelodysplastic syndr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2020-02-18